|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 401/14 | (2006.01) |
| C07D 213/82 | (2006.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61K 31/44 | (2006.01) |
| (11) | Number of the document | 3436446 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17716763.2 |
| Date of filing the European patent application | 2017-03-31 | |
| (97) | Date of publication of the European application | 2019-02-06 |
| (45) | Date of publication and mention of the grant of the patent | 2023-06-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/025381 |
| Date | 2017-03-31 |
| (87) | Number | WO 2017/173274 |
| Date | 2017-10-05 |
| (30) | Number | Date | Country code |
| 201662316043 P | 2016-03-31 | US |
| (72) |
BEAR, Brian , US
CLEMENS, Jeremy , US
CLEVELAND, Thomas , US
COON, Timothy, Richard , US
GROOTENHUIS, Peter, Diederik Jan , US
FRIEMAN, Bryan, A. , US
HADIDA RUAH, Sara S. , US
KHATUYA, Haripada , US
KRENITSKY, Paul, J. , US
MILLER, Mark, Thomas , US
SILINA, Alina , US
UY, Johnny , US
ZHOU, Jinglan , US
|
| (73) |
Vertex Pharmaceuticals Incorporated ,
50 Northern Avenue, Boston, MA 02210,
US
|
| (54) | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR |
| MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR |